"Guarding the health of the Sudan people"

Early in the morning, Bashil Hamid Haron, the quality department of Shanghai -Sudan Pharmaceutical Co., Ltd. came to the office early, put on a white coat, pierced into the laboratory, and started a busy work. "That's here, we realized the self -sufficiency of Sudan's anti -malaria drugs." Bohil said with a smile at the number flashed on the instrument.

Established in 1998, Shanghai -Sudan Pharmaceutical Co., Ltd. is located in the North Kha Moumou District of the important industrial zone of Sudan. Babik, the first chairman of Shanghai -Sudan Pharmaceutical Co., Ltd., recalled: "At that time, many pharmaceutical factories were destroyed in the continuous war of years. Among the more than 240 basic medicines commonly used by the public, local pharmaceutical factories can only supply the total demand for total demand. About 10%, the physical health of millions of people is threatened. At such difficulties, Chinese friends and us have saved the lives of many patients with practical actions. "

The primary task after the completion of Shanghai -Sudan Pharmaceutical Company is to achieve the localized production of urgently needed antimalarial drugs. Sudan has a population of less than 40 million, and hundreds of thousands of people suffering from malaria each year. The production of antimalarial drugs is to solve the urgent needs of the Sudan people. Today, the company's antimalarial drugs are completely localized, and the products have been updated to the fourth generation. The reporter saw in the production workshop that more than 200 Sudan workers were busy on the automatic assembly line, sorting raw materials, weighing, processing, packaging drugs, and cold chain cars ... work in an orderly manner. Salesman Haffz Sharif showed to reporters with the latest antimalarial drugs: "In the past, our drug output could only be supplied to the capital Kayoumu and the surrounding areas. The medicines have covered 16 states in Sudan, and they are selected by more than 4,000 medical institutions.

According to reports, over the past 20 years, China and the Soviet Union have continuously increased cooperative research and development. In addition to antimalarial drugs, they have also developed a large number of localized new drugs for treating diabetes, digestive tract diseases, and anti -infection. Liu Hongbo, general manager of Shanghai -Sudan Pharmaceutical Co., Ltd. pointed to a row of new factories outside the workshop: "Recently, our new antibiotic production workshop must also be put into use, and new products will further increase the proportion of drugs to the Sudan people. , More effective and better products. We will do our best to serve Sudan patients, and we hope to develop into influential pharmaceutical companies in Africa based on Sudan. "

Badladdin, general manager of the Sudan National Pharmaceutical Supply Fund, believes that Chinese pharmaceutical companies cooperate with Sudan to help Sudan realize localized production of basic drugs, and also cultivate a large number of talents in the pharmaceutical field for Sudan to help the overall level of Sudan pharmaceutical. According to reports, Shanghai -Sudan Pharmaceutical Co., Ltd. provides a study of studies for more than 300 local employees each year, and has trained a large number of professional talents over the years. "I am a good example." Bahill told reporters that with the support of the company, he obtained a master's degree in chemical engineering from 2010 to 2018, and also received the opportunity to train in China. "In China, I learned about advanced pharmaceutical technology and opened up their horizons. I hope that in the future, we can produce more and better medicines to protect the health of the Sudan people." Bahill said.

- END -